サポート>ブログ>カスタム抗体開発のためのCROソリューション

カスタム抗体開発のためのCROソリューション

Biointron 2024-12-12

The development of custom antibodies is a critical component in advancing research and therapeutic innovation. Biointron, a Contract Research Organization (CRO) specializing in antibody expression services, provides comprehensive support to biotech companies seeking reliable, scalable, and high-quality solutions for their antibody production needs.

Expertise in Antibody Discovery and Expression 

Biointron’s core strength lies in its expertise in the discovery, engineering, and expression of custom antibodies. The company employs advanced platforms for hybridoma development, phage display technology, and recombinant antibody expression to cater to a broad range of applications, including diagnostics, therapeutics, and basic research. 

One of Biointron’s key offerings is Abinvivo, a Biointron brand that provides in vivo antibodies and reagents for research use. Biointron’s catalog products for in vivo research can be found at Abinvivo, where we have a wide range of Benchmark Positive Antibodies, Isotype Negative Antibodies, Anti-Mouse Antibodies, Bispecific Antibodies, and Antibody-Drug Conjugates. 

Related: Abinvivo’s In Vivo Antibody Products: Differences in V3, V6, and V9 

Abinvivo also integrates analytical validation as part of our services. This ensures that each batch of antibodies meets the purity, stability, and functional requirements critical for success in downstream applications. 

Supporting Therapeutic Antibody Development 

The therapeutic antibody market continues to grow, driven by innovations in immuno-oncology, autoimmune disease therapies, and infectious disease research. Biointron supports these efforts by offering services like humanization of monoclonal antibodies, a key step in transitioning murine-derived antibodies for human clinical applications. 

A Trusted Partner for Antibody R&D 

Biointron is committed to maintaining transparent communication and collaboration throughout the project lifecycle. Our team of scientists works closely with clients to ensure the antibody development process aligns with project goals, budgets, and timelines. 

For biotech firms navigating complex research demands, partnering with Biointron offers a streamlined approach to custom antibody development. Our integrated solutions, technical expertise, and focus on quality provide the support necessary to bring innovative antibody-based products to market.

Subscribe to our ブログ
Recommended Articles
VHHs as Intrabodies (Intracellular Antibodies)

Explore VHH intrabodies for intracellular targeting, protein interaction studies……

May 20, 2026
Site-Directed Mutagenesis for Antibody Affinity Maturation

Learn how site-directed mutagenesis improves antibody affinity, binding specific……

May 18, 2026
Fusion with Fc Regions or Enzymes in VHH Antibody Engineering

Explore VHH Fc fusion and enzyme strategies to improve antibody half-life, effec……

May 16, 2026
2026 Annual Conference of the Chinese Antibody Society (ChAbS): Highlights and Event Recap

The 2026 ChAbS Annual Conference, “10 Years Together: Forging the Future of Anti……

May 14, 2026

お客様の利便性を向上させるためにクッキーを使用しています。詳しくは プライバシーポリシー をご覧ください。